CN1772194A - 一种壮阳强肾的中草药剂 - Google Patents
一种壮阳强肾的中草药剂 Download PDFInfo
- Publication number
- CN1772194A CN1772194A CNA2005100129329A CN200510012932A CN1772194A CN 1772194 A CN1772194 A CN 1772194A CN A2005100129329 A CNA2005100129329 A CN A2005100129329A CN 200510012932 A CN200510012932 A CN 200510012932A CN 1772194 A CN1772194 A CN 1772194A
- Authority
- CN
- China
- Prior art keywords
- radix
- yang
- kidney
- rhizoma
- tonifying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000005728 strengthening Methods 0.000 title abstract description 11
- 241000411851 herbal medicine Species 0.000 title abstract description 4
- 241000208340 Araliaceae Species 0.000 claims abstract description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 5
- 235000008434 ginseng Nutrition 0.000 claims abstract description 5
- 210000003734 kidney Anatomy 0.000 claims description 44
- 239000003814 drug Substances 0.000 claims description 13
- 210000000582 semen Anatomy 0.000 claims description 13
- 241000628997 Flos Species 0.000 claims description 5
- 241000180649 Panax notoginseng Species 0.000 claims description 5
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 5
- 241000131808 Scolopendra Species 0.000 claims description 5
- 210000001161 mammalian embryo Anatomy 0.000 claims description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 5
- 241000005787 Cistanche Species 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- 235000005903 Dioscorea Nutrition 0.000 claims description 2
- 241000234273 Dioscorea Species 0.000 claims description 2
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 2
- 241000305492 Gastrodia Species 0.000 claims description 2
- 241000208966 Polygala Species 0.000 claims description 2
- 241000207929 Scutellaria Species 0.000 claims description 2
- 239000007963 capsule composition Substances 0.000 claims description 2
- 235000004879 dioscorea Nutrition 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 52
- 230000006870 function Effects 0.000 abstract description 7
- 230000035790 physiological processes and functions Effects 0.000 abstract description 5
- 208000028867 ischemia Diseases 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 230000000747 cardiac effect Effects 0.000 abstract description 2
- 230000002490 cerebral effect Effects 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 240000007371 Cuscuta campestris Species 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 241000157491 Morinda Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 208000030961 allergic reaction Diseases 0.000 abstract 1
- 210000003056 antler Anatomy 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 235000017524 noni Nutrition 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 19
- 210000004185 liver Anatomy 0.000 description 17
- 235000009508 confectionery Nutrition 0.000 description 16
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 12
- 210000003205 muscle Anatomy 0.000 description 11
- 210000000988 bone and bone Anatomy 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 230000001914 calming effect Effects 0.000 description 6
- 201000001881 impotence Diseases 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 5
- 206010059013 Nocturnal emission Diseases 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000001568 sexual effect Effects 0.000 description 5
- 230000008093 supporting effect Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 241000201295 Euphrasia Species 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 210000005013 brain tissue Anatomy 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 210000005003 heart tissue Anatomy 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 206010036596 premature ejaculation Diseases 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000002443 hepatoprotective effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 206010027175 memory impairment Diseases 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000036299 sexual function Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003257 anti-anginal effect Effects 0.000 description 1
- 230000001437 anti-cataract Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- -1 calms the nerves Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 1
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
杜仲 | 20 | 30 | 22 | 24 | 26 | 28 | 25 | 30 | 20 |
西洋参 | 5 | 25 | 5 | 20 | 15 | 10 | 20 | 10 | 15 |
淫羊藿 | 10 | 25 | 20 | 15 | 10 | 25 | 15 | 20 | 10 |
茯苓 | 15 | 30 | 30 | 10 | 20 | 25 | 30 | 15 | 20 |
天麻 | 15 | 25 | 20 | 20 | 15 | 25 | 25 | 15 | 20 |
蜈蚣 | 1 | 3 | 2 | 1.5 | 2.5 | 3 | 1 | 2 | 1.5 |
枸杞子 | 20 | 30 | 22 | 24 | 26 | 28 | 30 | 20 | 25 |
百合 | 10 | 25 | 20 | 15 | 10 | 25 | 20 | 15 | 20 |
远志 | 10 | 25 | 15 | 25 | 20 | 10 | 15 | 20 | 15 |
当归 | 15 | 25 | 20 | 17 | 19 | 21 | 23 | 15 | 25 |
黄精 | 15 | 25 | 25 | 20 | 17 | 19 | 21 | 23 | 15 |
何首乌 | 10 | 25 | 20 | 15 | 25 | 10 | 20 | 15 | 25 |
龟板 | 15 | 30 | 20 | 25 | 15 | 30 | 15 | 30 | 20 |
黄芩 | 25 | 30 | 26 | 27 | 28 | 29 | 30 | 25 | 30 |
川芎 | 10 | 25 | 15 | 20 | 20 | 15 | 25 | 10 | 20 |
三七 | 20 | 25 | 24 | 23 | 22 | 21 | 20 | 25 | 22 |
蛇床子 | 20 | 30 | 28 | 26 | 24 | 22 | 25 | 30 | 20 |
丁香 | 20 | 30 | 22 | 24 | 26 | 28 | 30 | 30 | 25 |
莲子芯 | 5 | 20 | 15 | 10 | 20 | 10 | 5 | 15 | 5 |
山药 | 15 | 35 | 25 | 15 | 20 | 35 | 15 | 25 | 20 |
锁阳 | 25 | 30 | 26 | 27 | 28 | 29 | 30 | 25 | 28 |
白芍 | 15 | 25 | 17 | 19 | 21 | 23 | 25 | 15 | 20 |
沙苑子 | 10 | 25 | 15 | 20 | 10 | 15 | 25 | 20 | 15 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100129329A CN1318044C (zh) | 2005-10-21 | 2005-10-21 | 一种壮阳强肾的中草药剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100129329A CN1318044C (zh) | 2005-10-21 | 2005-10-21 | 一种壮阳强肾的中草药剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1772194A true CN1772194A (zh) | 2006-05-17 |
CN1318044C CN1318044C (zh) | 2007-05-30 |
Family
ID=36759446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100129329A Expired - Fee Related CN1318044C (zh) | 2005-10-21 | 2005-10-21 | 一种壮阳强肾的中草药剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1318044C (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102940766A (zh) * | 2012-10-10 | 2013-02-27 | 肥西县中医院 | 一种治疗慢性肾炎的中药 |
CN102949627A (zh) * | 2012-11-29 | 2013-03-06 | 北京中融阳光投资管理有限公司 | 一种补肾健脾的侗药药酒及其制备方法 |
CN103191312A (zh) * | 2013-03-29 | 2013-07-10 | 贾建有 | 益肾健身药品 |
CN103623218A (zh) * | 2012-08-24 | 2014-03-12 | 上海锦医堂投资管理有限公司 | 一种具有强体、养神功效的中药组合物 |
CN105169358A (zh) * | 2015-10-30 | 2015-12-23 | 徐杰 | 一种益元回春保健酒及其制作方法 |
WO2016065694A1 (zh) * | 2014-10-31 | 2016-05-06 | 冼淑芬 | 一种有益于男性生育的保健粥及其制备方法 |
CN105709160A (zh) * | 2016-03-30 | 2016-06-29 | 张量才 | 一种补肾填精、滋阴壮阳、强魄体质的保健酒 |
CN106310132A (zh) * | 2016-09-30 | 2017-01-11 | 杨巧霞 | 治疗肝气郁结证型阳痿的中药煎煮液 |
CN103340405B (zh) * | 2013-07-11 | 2017-07-28 | 陕西大志药业有限公司 | 一种缓解体力疲劳的保健食品及其制备方法 |
CN108715786A (zh) * | 2018-05-02 | 2018-10-30 | 赵楠 | 一种中草蒙医药保健酒及其制备方法 |
CN109674981A (zh) * | 2019-03-07 | 2019-04-26 | 贾建真 | 一种治疗男性性功能障碍的中药配方及其制备方法 |
CN110710681A (zh) * | 2018-07-11 | 2020-01-21 | 上海天龙生物科技有限公司 | 一种提高精力、缓解疲劳的保健组合物及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1096679A (zh) * | 1993-06-19 | 1994-12-28 | 张士舜 | 一种男用性功能促进剂 |
CN1189360A (zh) * | 1997-01-28 | 1998-08-05 | 许其辉 | 生精药 |
CN1255361A (zh) * | 1999-09-10 | 2000-06-07 | 刘福明 | 一种多功能保健酒 |
-
2005
- 2005-10-21 CN CNB2005100129329A patent/CN1318044C/zh not_active Expired - Fee Related
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103623218A (zh) * | 2012-08-24 | 2014-03-12 | 上海锦医堂投资管理有限公司 | 一种具有强体、养神功效的中药组合物 |
CN102940766B (zh) * | 2012-10-10 | 2014-06-11 | 肥西县中医院 | 一种治疗慢性肾炎的中药 |
CN102940766A (zh) * | 2012-10-10 | 2013-02-27 | 肥西县中医院 | 一种治疗慢性肾炎的中药 |
CN102949627A (zh) * | 2012-11-29 | 2013-03-06 | 北京中融阳光投资管理有限公司 | 一种补肾健脾的侗药药酒及其制备方法 |
CN103191312A (zh) * | 2013-03-29 | 2013-07-10 | 贾建有 | 益肾健身药品 |
CN103191312B (zh) * | 2013-03-29 | 2014-07-16 | 贾建有 | 益肾健身药品 |
CN103340405B (zh) * | 2013-07-11 | 2017-07-28 | 陕西大志药业有限公司 | 一种缓解体力疲劳的保健食品及其制备方法 |
WO2016065694A1 (zh) * | 2014-10-31 | 2016-05-06 | 冼淑芬 | 一种有益于男性生育的保健粥及其制备方法 |
CN105169358A (zh) * | 2015-10-30 | 2015-12-23 | 徐杰 | 一种益元回春保健酒及其制作方法 |
CN105709160A (zh) * | 2016-03-30 | 2016-06-29 | 张量才 | 一种补肾填精、滋阴壮阳、强魄体质的保健酒 |
CN106310132A (zh) * | 2016-09-30 | 2017-01-11 | 杨巧霞 | 治疗肝气郁结证型阳痿的中药煎煮液 |
CN108715786A (zh) * | 2018-05-02 | 2018-10-30 | 赵楠 | 一种中草蒙医药保健酒及其制备方法 |
CN110710681A (zh) * | 2018-07-11 | 2020-01-21 | 上海天龙生物科技有限公司 | 一种提高精力、缓解疲劳的保健组合物及其制备方法 |
CN109674981A (zh) * | 2019-03-07 | 2019-04-26 | 贾建真 | 一种治疗男性性功能障碍的中药配方及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1318044C (zh) | 2007-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1318044C (zh) | 一种壮阳强肾的中草药剂 | |
CN102614442A (zh) | 增力、益血、止吐中药胶囊 | |
CN102861235B (zh) | 一种纯中药养生制剂 | |
CN102715509B (zh) | 一种排毒养颜保健品 | |
CN1211112C (zh) | 固本回元中药组合物及其口服液制造方法 | |
CN101041006A (zh) | 一种内服治疗冠心病的中药组合物 | |
CN103520668B (zh) | 一种治疗心气不足证型胸痹心痛的中药 | |
CN1184989C (zh) | 作用于穴位的减肥中药 | |
CN102579799B (zh) | 一种治疗产后血虚发热型的中药组合物 | |
CN1286995A (zh) | 治疗类风湿病的中药酒及其制造方法 | |
CN104548049A (zh) | 一种治疗老年性骨质疏松症的中药组合物及其制备方法 | |
CN1211434A (zh) | 一种抗高原反应口服液及其制备方法 | |
CN102973687B (zh) | 调节妇女内分泌平衡的口服液 | |
CN101703660B (zh) | 一种抗衰老药物 | |
CN105796749B (zh) | 一种缓解视疲劳的中药组合物 | |
CN1270744C (zh) | 用于治疗腰椎间盘突出症的骨康健生丸 | |
CN1245197C (zh) | 治疗冠心病、病毒性心肌炎的中药制剂 | |
CN1286105A (zh) | 配合穴位治疗的灸药 | |
CN1259953C (zh) | 一种抗衰老保健药物 | |
CN101569708B (zh) | 一种治疗缺血性心脏病的药物及其制备方法 | |
CN105125778A (zh) | 一种改善睡眠、缓解疲劳的足浴粉及其制备和使用方法 | |
CN105213793A (zh) | 主治骨质疏松的中药组合物及制法 | |
CN104524535A (zh) | 一种治疗慢性肺源性心脏病的中药组合物及其制备方法 | |
CN103341030B (zh) | 一种治疗白血病的中药组合物 | |
CN104042908A (zh) | 一种治疗妇女更年期综合症的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: YU LILI Free format text: FORMER OWNER: CHEN JIANHUI Effective date: 20100108 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20100108 Address after: Hebei province Shijiazhuang City Xinshi Road No. 229 11-1-102 Patentee after: Yu Lili Address before: Hebei city in Shijiazhuang Province, Xinhua District Garden District 50-306 Patentee before: Chen Jianhui |
|
ASS | Succession or assignment of patent right |
Owner name: YU LILI Owner name: HEBEI MEDICAL UNIVERSITY Free format text: FORMER OWNER: YU LILI Effective date: 20110803 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 050091 SHIJIAZHUANG, HEBEI PROVINCE TO: 050017 SHIJIAZHUANG, HEBEI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110803 Address after: 050017 Zhongshan East Road, Hebei, China, No. 361, No. Co-patentee after: Yu Lili Patentee after: Hebei Medical University Address before: 050091 Hebei province Shijiazhuang City Xinshi Road No. 229 11-1-102 Patentee before: Yu Lili |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070530 Termination date: 20111021 |